"Now we can see there are different patterns of inflammation, we can be smarter and get the right treatment, to the right patient, at the right time," said Prof Mona Bafadhel, from King's.
People treated with the new therapy were less likely to be admitted to hospital, need another round of treatment or die.
The study monitored patients for three months after treatment for a flare-up, revealing a treatment failure rate of 74% when taking steroids and 45% with the new therapy.
This is a game-changer, we've not had a change in treatment for 50 years - it will revolutionise how we treat people when they're really unwell." Prof Bafadhel.
Collection
[
|
...
]